Prolapse and cervical carcinoma: a case study

Authors

Keywords:

pelvic organ prolapse, uterine prolapse, uterine neoplasms

Abstract

Introduction: cervical cancer is the most common gynecological malignancy worldwide, however, uterovaginal prolapse colligated to cervical carcinoma is not standardized and therapeutic strategies vary considerably among authors.
Patient information: a 74-year-old postmenopausal patient with a history of arterial hypertension and type 2 diabetes mellitus is presented. In addition to a long history of uterovaginal prolapse, with a history of multiparity. She was admitted with an injury related to pelvic organ prolapse, the patient was unable to describe the duration of her postmenopausal process, but reported that the prolapse began to protrude beyond the vagina for 6 months prior to presentation. Then, the patient began to notice vaginal bleeding, local pain, and fever. Biopsy of the cervical lesion confirmed a moderately differentiated infiltrating epidermoid carcinoma of the exocervix.
Conclusions: pelvic organ prolapse is a disease that occurs more frequently in elderly women, mainly associated with increasing age, obesity and high parity, one of its main complications is cervical carcinoma. Generally, women who present this disease need procedures such as primary surgery with adjuvant therapy, radiotherapy or chemotherapy.

Downloads

Download data is not yet available.

Author Biographies

Maurice José González Basulto, Universidad de Ciencias Médicas de Camagüey

Licenciado en Radiofísica Médica. Máster en Educación Ambiental. Profesor Auxiliar en la Universidad de Ciencias Médicas de Camagüey. Investigador Agregado.

Gustavo de Jesús Crespo Campo, Hospital Provincial Oncológico Universitario "María Curie"

Doctor en Medicina. Especialista de II Grado en Ginecoobstetricia. Profesor Auxiliar en la Universidad de Ciencias Médicas de Camagüey.

Dayan Cervantes Peláez, Hospital Provincial Oncológico Universitario "María Curie"

Especialista de II Grado en Coloproctología. Especialista de II Grado en Oncología Médica. Máster en Humanidades Médicas. Profesor Asistente en la Universidad de Ciencias Médicas de Camagüey.

References

1.Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett [Internet]. 2020 [citado 03/03/2023];20(3):2058-2074. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400218/. https://doi.org/10.3892/ol.2020.11754

2.Shrestha B, Onta S, Choulagai B, Paudel R, Petzold M, Krettek A. Uterine prolapse and its impact on quality of life in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Bhaktapur, Nepal. Glob Health Action [Internet]. 2015 [citado 03/03/2023];8:28771. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532727/. https://doi.org/10.3402/gha.v8.28771

3.Abdel-Fattah M, Familusi A, Fielding S, Ford J, Bhattacharya S. Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study. BMJ Open [Internet]. 2011 [citado 03/03/2023];1(2):e000206. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221293/. https://doi.org/10.1136/bmjopen-2011-000206

4.Jacomina LE, Garcia MC, Santiago AC, Tagayuna IM, Bacorro WR. Chemoradiotherapy in a patient with locally advanced small cell neuroendocrine carcinoma of the cervix complicated by pelvic organ prolapse: a case report. Gynecol Oncol Rep [Internet]. 2021 [citado 03/03/2023];37:100832. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283320/. https://doi.org/10.1016/j.gore.2021.100832

5.Kahn RM, Gordhandas S, Craig K, Dune TJ, Holcomb K, Chapman-Davis E, et al. Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management. Ecancermedicalscience [Internet]. 2020 [citado 03/03/2023];14:1043. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289612/. https://doi.org/10.3332/ecancer.2020.1043

6.Dawkins J, Lewis G, Toy E. Cervical cancer complicating pelvic organ prolapse, and use of a pessary to restore anatomy for optimal radiation: a case report. Gynecol Oncol Rep [Internet]. 2018 [citado 03/03/2023];26:14-16. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106706/. https://doi.org/10.1016/j.gore.2018.08.004

7.Wang Z, Ren X, Liu Z, Li Y, Wang T. Multimodality treatment for multiple recurrences of cervical cancer after radiotherapy: a case report. Transl Cancer Res [Internet]. 2022 [citado 03/03/2023];11(4):943-951. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091019/. https://doi.org/10.21037/tcr-21-2250

8.Grimes WR, Stratton M. Pelvic Exenteration [Internet]. Treasure Island: StatPearls Publishing; 2023 [citado 03/03/2023]. Disponible en: https://www.ncbi.nlm.nih.gov/books/nbk563269/

9.Skręt A, Trawińska J, Bielatowicz J, Książek M, Niewęgłowska-Guzik B, Radkowski A, et al. Synchronous occurrence of HPV-associated cervical squamous cell carcinoma (FIGO IIA) in prolapsed uterus and adenocarcinoma of the anal canal cT1N0M0. Medicine (Baltimore) [Internet]. 2021 [citado 03/03/2023];100(50):e28004. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677995/. https://doi.org/10.1097/md.0000000000028004

10.Lee DJ, Joo JK, Suh DS, Shin BS, Hwang SY, Kim KH. Successful treatment of locally advanced bulky cervical cancer complicated by irreducible complete uterine prolapse: A case report. Medicine (Baltimore) [Internet]. 2022 [citado 03/03/2023];101(3):e28664. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772643/. https://doi.org/10.1097/md.0000000000028664

11.Lemm M, Słowik Ł, Cichoń B, Poński M, Szwaczka Ł, Bakon I, et al. Basaloid squamous cell carcinoma of the uterine cervix coexisting with undifferentiated sarcoma. Prz Menopauzalny [Internet]. 2020 [citado 03/03/2023];19(4):192-194. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812537/. https://doi.org/10.5114/pm.2020.101944

12.Pardal C, Correia C, Serrano P. Carcinoma of the cervix complicating a genital prolapse. BMJ Case Rep [Internet]. 2015 [citado 03/03/2023];2015:bcr2015209580. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458593/. https://doi.org/10.1136/bcr-2015-209580

13.Onigahara M, Yanazume S, Ushiwaka T, Togami S, Kamio M, Kobayashi H. Importance of Cervical Elongation Assessment for Laparoscopic Sacrocolpopexy. Gynecol Minim Invasive Ther [Internet]. 2021 [citado 03/03/2023];10(2):127-131. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140543/. https://doi.org/10.4103/gmit.gmit_114_19

14.Gill CM, Orfanelli T, Yoxtheimer L, Roy-McMahon C, Suhner J, Tomita S, et al. Histology-specific FGFR2 alterations and FGFR2-TACC2 fusion in mixed adenoid cystic and neuroendocrine small cell carcinoma of the uterine cervix. Gynecol Oncol Rep [Internet]. 2020 [citado 03/03/2023];34:100668. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672274/. https://doi.org/10.1016/j.gore.2020.100668

15.Vijayakumar A, Maroney S, Husain S. Stomal recurrence of cervical cancer after pelvic exenteration. Curr Probl Cancer [Internet]. 2021 [citado 03/03/2023];3:100052. Disponible en: https://www.sciencedirect.com/science/article/pii/S2666621921000016. https://doi.org/10.1016/j.cpccr.2021.100052

Published

2023-10-31

How to Cite

1.
González Basulto MJ, Crespo Campo G de J, Cervantes Peláez D. Prolapse and cervical carcinoma: a case study. Acta Méd Centro [Internet]. 2023 Oct. 31 [cited 2025 Aug. 21];17(4):779-84. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1920